Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Short-term Investments (2017 - 2026)

Bioceres Crop Solutions' Short-term Investments history spans 10 years, with the latest figure at -$500000.0 for Q1 2026.

  • On a quarterly basis, Short-term Investments rose 44.44% to -$500000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$500000.0, a 44.44% increase, with the full-year FY2025 number at $13.2 million, down 32.27% from a year prior.
  • Short-term Investments hit -$500000.0 in Q1 2026 for Bioceres Crop Solutions, down from $13.2 million in the prior quarter.
  • Over the last five years, Short-term Investments for BIOX hit a ceiling of $19.5 million in Q2 2024 and a floor of -$900000.0 in Q1 2025.
  • Historically, Short-term Investments has averaged $8.1 million across 5 years, with a median of $8.8 million in 2022.
  • Biggest five-year swings in Short-term Investments: tumbled 51.61% in 2022 and later soared 124.68% in 2023.
  • Tracing BIOX's Short-term Investments over 5 years: stood at $5.4 million in 2022, then soared by 124.68% to $12.1 million in 2023, then surged by 60.69% to $19.5 million in 2024, then plummeted by 32.27% to $13.2 million in 2025, then tumbled by 103.79% to -$500000.0 in 2026.
  • Business Quant data shows Short-term Investments for BIOX at -$500000.0 in Q1 2026, $13.2 million in Q2 2025, and -$900000.0 in Q1 2025.